Article Text
What neurologists need to
Preserving fertility: using cyclophosphamide and other cytotoxics in young people
Abstract
Cytotoxic agents such as cyclophosphamide are infrequently used in neurological practice. When they are, it is commonly in critically ill patients or in those with refractory inflammatory disorders. Cyclophosphamide in particular has a well-recognised negative impact on both female and male long-term fertility. This article summarises the data with regards the impact of cytotoxics on long-term fertility and describes the current options to preserve fertility in these patients. We hope this will provide neurologists with a useful aid for counselling patients for whom they are considering these treatments.
- Cyclophosphamide
- Fertility
- Cytotoxic
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Fertility considerations prior to conservative management of gynecologic cancers
- Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes
- Fifteen-minute consultation: Fertility preservation in children with cancer
- Gender-specific aspects related to type of fertility preservation strategies and access to fertility care
- Fertility preservation in patients with BRCA mutations or Lynch syndrome
- Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists
- Why are women considering ovarian tissue cryopreservation to preserve reproductive and hormonal ovarian function? A qualitative study protocol
- Feasibility of in vitro maturation of oocytes collected from patients with malignant ovarian tumors undergoing fertility preservation
- Fertility preservation for female patients with childhood and adolescent cancer
- Preserving fertility in girls and young women with cancer